Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genomics of Immune Diseases and New Therapies.

Annual review of immunology - 20 May 2016

Lenardo Michael, Lo Bernice, Lucas Carrie L

Abstract excerpt

Genomic DNA sequencing technologies have been one of the great advances of the 21st century, having decreased in cost by seven orders of magnitude and opening up new fields of investigation throughout research and clinical medicine. Genomics coupled with biochemical investigation has allowed the molecular definition of a growing number of new genetic diseases that reveal new concepts of immune regulation. Also,...

Topics

Join the communities discussing this publication.

Cation Transport Proteins
CTLA-4 Antigen
Genomics
High-Throughput Nucleotide Sequencing
Immune System Diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Molecular Targeted Therapy

Phosphatidylinositol 3-Kinases

Source

Open in PubMed Open full text

Identifiers

PMID: 26735698
DOI: 10.1146/annurev-immunol-041015-055620
PMCID: PMC5736009

Genes

MAGT1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genomics of Immune Diseases and New Therapies.PMID 26735698Read ↗

Defective glycosylation and multisystem abnormalities characterize the primary immunodeficiency XMEN diseaseSemantic proximity Read ↗

Magnesium transporter 1 (MAGT1) deficiency causes selective defects in N-linked glycosylation and expression of immune-response genesSemantic proximity Read ↗

An Update on XMEN Disease.Semantic proximity Read ↗

Identification of a novel MAGT1 mutation supports a diagnosis of XMEN disease.Semantic proximity Read ↗

Identification of a novel mutation in MAGT1 and progressive multifocal leucoencephalopathy in a 58-year-old man with XMEN disease.Semantic proximity Read ↗

Scales of Magt1 Gene: Novel Mutations, Different Presentations.Semantic proximity Read ↗

X-linked immunodeficiency with magnesium defect, Epstein–Barr virus infection, and neoplasia diseaseSemantic proximity Read ↗

MAGT1 gene mutation causes myositis and CD127 expression downregulationSemantic proximity Read ↗

Unexpected genetically determined immune dysregulation with liver involvement: GIMAP5 therapeutic dilemmas between targeted therapy and HSCT.Semantic proximity Read ↗

Modifier-Sensitive Phenotypic Divergence in XMEN Disease (MAGT1 Deficiency): Neurodegenerative and Hematologic TrajectoriesSemantic proximity Read ↗

Lymphoma arising in the setting of inborn errors of immunity: A six-case series of XMEN-associated pediatric lymphomaSemantic proximity Read ↗

Case Report: A successful case of allogeneic stem cell transplantation for pediatric XMEN characterized by neutropenia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.